Sector valuations Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
15:05:07 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,720.50 INR | +0.34% |
|
+8.12% | +48.01% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 35.59x | 4.99x | 2.66x | 6.69x | 23.19x | 28.06x | 0.89% | 48.77B | |
| 17.84x | 1.98x | 13.01x | 2.24x | 10.09x | 12.79x | 1.45% | 40.67B | |
| 28x | 3.86x | -1.67x | 3.99x | 16.54x | 23.17x | 0.58% | 12.27B | |
| 27.7x | 3.06x | 3.94x | 3.37x | 17.45x | 22.38x | 0.91% | 12.11B | |
| 19.06x | 3.3x | 3.77x | 3.39x | 11.8x | 14.06x | 3.78% | 9.28B | |
| 9.6x | 1.58x | 1.29x | 2.21x | 5.72x | 7.01x | 4.51% | 7.55B | |
| 30.05x | 5.51x | 0.43x | 3.93x | 18.3x | 22.06x | 0.15% | 7.35B | |
| 16.03x | 1.33x | 3.62x | 2.11x | 6.82x | 9.8x | 3.15% | 7.3B | |
| 34.89x | 8.08x | 1.85x | 6.81x | 24.86x | 27.44x | 0.95% | 4.61B | |
| 15.9x | 0.77x | -0.03x | 2.19x | 9.37x | 11.85x | 1.7% | 4.31B | |
| 13.73x | 2.3x | 0.51x | 2.27x | 10.17x | 10.01x | 3.83% | 3.6B | |
| 16.65x | 2.95x | -9.92x | 3.37x | 12.7x | 15.16x | 2.93% | 2.91B | |
| 11.71x | - | 2.9x | 9.05x | 8.41x | 8.61x | - | 2.54B | |
| 19.65x | 4.99x | 4.42x | 5.61x | 16.81x | 18.38x | 3.07% | 2.54B | |
| 31.09x | - | -0.12x | - | - | - | - | 2.41B | |
| Average | 21.83x | 3.44x | 1.78x | 4.09x | 13.73x | 16.48x | 2.15% | 11.21B | |
| Weighted average by Cap. | 25.02x | 3.50x | 4.52x | 4.20x | 15.59x | 19.22x | 1.56% |
Select your edition
All financial news and data tailored to specific country editions
